Published in BMJ Open on May 21, 2012
Comprehensive Molecular Testing for Respiratory Pathogens in Community-Acquired Pneumonia. Clin Infect Dis (2016) 3.58
Incidence and predictors of hospitalization for bacterial infection in community-based patients with type 2 diabetes: the fremantle diabetes study. PLoS One (2013) 1.00
Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia. BMJ Open Respir Res (2014) 0.80
A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med (1997) 24.87
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax (2003) 9.54
Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med (2007) 5.65
Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J (2006) 5.31
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax (2001) 4.68
Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med (2006) 4.24
Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ (2006) 3.62
Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax (2010) 3.30
Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med (2005) 3.13
Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol (1993) 2.90
Predicting death in patients hospitalized for community-acquired pneumonia. Ann Intern Med (1991) 2.85
PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia. Crit Care Med (2009) 2.59
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis (2008) 2.56
Community acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax (1996) 2.46
Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis. Thorax (2010) 2.20
Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur Respir J (1997) 1.75
A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia. Thorax (2006) 1.62
Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother (2008) 1.45
Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong Kong. Thorax (2006) 1.35
Treatment costs of community-acquired pneumonia in an employed population. Chest (2004) 1.27
Infections in the alcoholic. Med Clin North Am (1984) 1.15
Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia. Respirology (2008) 1.11
Severity assessment in community-acquired pneumonia: a review. QJM (2009) 1.04
Epidemiology, clinical features and outcomes of pneumonia in patients with chronic kidney disease. Nephrol Dial Transplant (2011) 1.02
The role of pneumonia scores in the emergency room in patients infected by 2009 H1N1 infection. Eur J Emerg Med (2012) 0.99
Risk adjusting community-acquired pneumonia hospital outcomes using automated databases. Am J Manag Care (2008) 0.99
Identifying severe community-acquired pneumonia in the emergency department: a simple clinical prediction tool. Emerg Med Australas (2007) 0.95
Performance of CURB-65 and CURB-age in community-acquired pneumonia. Int J Clin Pract (2009) 0.95
Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores. Medicine (Baltimore) (2011) 0.94
Confusion, Urea, Respiratory Rate and Shock Index or Adjusted Shock Index (CURSI or CURASI) criteria predict mortality in community-acquired pneumonia. Eur J Intern Med (2010) 0.89
Predicting death in elderly patients with community-acquired pneumonia: a prospective validation study reevaluating the CRB-65 severity assessment tool. Arch Intern Med (2008) 0.89
Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience. Int J Antimicrob Agents (2004) 0.83
Low CURB-65 is of limited value in deciding discharge of patients with community-acquired pneumonia. Respir Med (2011) 0.82
Community-acquired pneumonia: severity of illness evaluation. Infect Dis Clin North Am (2004) 0.81
Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia. Scand J Infect Dis (2011) 0.81
Clinical management of immunocompetent hospitalized patients with community-acquired pneumonia. Eur J Intern Med (2004) 0.80
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ (2004) 21.24
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37
A randomized trial of protocol-based care for early septic shock. N Engl J Med (2014) 16.05
Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA (2002) 9.89
RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care (2006) 9.29
Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med (2012) 8.84
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med (2007) 8.33
Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care (2006) 7.99
A meta-analysis of the association between adherence to drug therapy and mortality. BMJ (2006) 7.79
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med (2010) 6.69
Outcomes of medical emergencies on commercial airline flights. N Engl J Med (2013) 6.29
Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet (2011) 6.25
Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ (2011) 6.19
National estimates of severe sepsis in United States emergency departments. Crit Care Med (2007) 5.99
Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med (2007) 5.65
Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis (2009) 5.23
Nighttime intensivist staffing and mortality among critically ill patients. N Engl J Med (2012) 5.22
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA (2007) 5.02
Variation in critical care services across North America and Western Europe. Crit Care Med (2008) 5.00
Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care (2005) 4.78
The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med (2002) 4.72
The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med (2010) 4.64
Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet (2007) 4.47
The effect of multidisciplinary care teams on intensive care unit mortality. Arch Intern Med (2010) 4.41
Out-of-hospital endotracheal intubation and outcome after traumatic brain injury. Ann Emerg Med (2004) 4.33
Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med (2006) 4.24
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies. BMJ (2011) 4.05
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ (2007) 3.95
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA (2013) 3.78
Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Arch Intern Med (2002) 3.78
New evidence for stroke prevention: scientific review. JAMA (2002) 3.70
Thiazolidinediones and heart failure: a teleo-analysis. Diabetes Care (2007) 3.62
Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ (2006) 3.62
Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med (2008) 3.44
Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome. Am J Respir Crit Care Med (2012) 3.36
Effect of pay for performance on the management and outcomes of hypertension in the United Kingdom: interrupted time series study. BMJ (2011) 3.29
The epidemiology of mechanical ventilation use in the United States. Crit Care Med (2010) 3.28
Advancing health disparities research within the health care system: a conceptual framework. Am J Public Health (2006) 3.25
Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial. Ann Emerg Med (2007) 3.22
Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ (2009) 3.18
Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med (2003) 3.18
Racial variation in the incidence, care, and outcomes of severe sepsis: analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med (2007) 3.17
The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*. Crit Care Med (2014) 3.17
Intensive care unit quality improvement: a "how-to" guide for the interdisciplinary team. Crit Care Med (2006) 3.15
Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med (2005) 3.13
Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med (2011) 3.13
Pneumonia: still the old man's friend? Arch Intern Med (2003) 3.12
Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes. Diabetes Care (2002) 3.12
Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int (2002) 3.07
A clinical prediction rule for diagnosing severe acute respiratory syndrome in the emergency department. Ann Intern Med (2004) 3.05
Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study. Thorax (2013) 3.05
Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med (2002) 3.02
Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial. Thorax (2012) 3.01
Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int (2009) 2.97
Prospective meta-analysis using individual patient data in intensive care medicine. Intensive Care Med (2009) 2.93
Organizational characteristics, outcomes, and resource use in 78 Brazilian intensive care units: the ORCHESTRA study. Intensive Care Med (2015) 2.92
Three-year outcomes for Medicare beneficiaries who survive intensive care. JAMA (2010) 2.87
The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med (2006) 2.84
Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine (2003) 2.76
Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem (2002) 2.74
The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med (2012) 2.72
Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest (2006) 2.69
Prevalence of survivor bias in observational studies on fresh frozen plasma:erythrocyte ratios in trauma requiring massive transfusion. Anesthesiology (2012) 2.68
Trends in the epidemiology of pediatric severe sepsis*. Pediatr Crit Care Med (2013) 2.67
Critical care medicine training and certification for emergency physicians. Ann Emerg Med (2005) 2.67
Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J (2005) 2.66
End-of-life care for the critically ill: A national intensive care unit survey. Crit Care Med (2006) 2.61
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis (2008) 2.56
Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ (2004) 2.55
Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid. Arch Intern Med (2009) 2.54
Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med (2005) 2.51
Disability among elderly survivors of mechanical ventilation. Am J Respir Crit Care Med (2010) 2.50
Coxiella burnetii genotyping. Emerg Infect Dis (2005) 2.50
Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J Bone Miner Res (2004) 2.47
Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol (2005) 2.45
Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol (2007) 2.44
Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med (2003) 2.44
Harmonizing international trials of early goal-directed resuscitation for severe sepsis and septic shock: methodology of ProCESS, ARISE, and ProMISe. Intensive Care Med (2013) 2.44
Prioritizing the organization and management of intensive care services in the United States: the PrOMIS Conference. Crit Care Med (2007) 2.42
Relationship between staff perceptions of hospital norms and hospital-level end-of-life treatment intensity. J Palliat Med (2007) 2.39
Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med (2003) 2.39